Focal Therapy Using High-Intensity Focused Ultrasound for Low- and Intermediate-Risk Prostate Cancer: Results from a Prospective, Multicenter Feasibility Trial
Recent Publication
A new study led by OA Dr Gabor Rosta from the Division of Urology and Andrology at University Hospital St. Pölten shows that prostate cancer can be treated in a targeted and gentle manner using ultrasound. Only the tumour is irradiated - healthy tissue remains intact. 51 men with low or medium risk were followed for two years. Most of them needed no further treatment and the cancer was often no longer detectable. Side effects were minimal and quality of life remained stable.
Rosta, G., Turba, S., Mun, D.-H., Shehab, A., Saciri, L., Engelhardt, P. F., Weisz, P., Riedl, C., Ameli, G., Doblhammer, S., & Fajkovic, H. (2025). Focal Therapy Using High-Intensity Focused Ultrasound for Low- and Intermediate-Risk Prostate Cancer: Results from a Prospective, Multicenter Feasibility Trial. Cancers, 17(21), 3429. https://doi.org/10.3390/cancers17213429
OA Dr. Gabor Rosta
Division of Urology and Andrology (University Hospital St. Pölten)
OA Dr. Simon Turba
Division of Urology and Andrology (University Hospital St. Pölten)
OA Dong-Ho Mun MSc
Division of Urology and Andrology (University Hospital St. Pölten)
Dr. Azad Shehab
Division of Urology and Andrology (University Hospital St. Pölten)
Dr. Leon Saciri
Division of Urology and Andrology (University Hospital St. Pölten)
Prim. Univ.-Prof. PD Dr. Harun Fajkovic MSc FEBU
Division of Urology and Andrology (University Hospital St. Pölten)